 About one-third of patients with non-small-cell lung cancer NSCLC have inoperable, locally advanced stage III disease at diagnosis. The most satisfactory treatment for patients with locally advanced NSCLC is combination chemotherapy-radiotherapy CT-RT. However, the optimal interval between irradiation and chemotherapy as well as the most effective chemotherapy protocol remains to be defined. 